[Skip to Content]
[Skip to Content Landing]

Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021A Systematic Review

To identify the key insights or developments described in this article
1 Credit CME
Key Points

Question  Are patient-reported outcome measures (PROMs) commonly used in acne and rosacea randomized clinical trials (RCTs)?

Findings  In this systematic review of 206 RCTs, 53% of rosacea and acne trials included at least 1 PROM. Only 7% of the RCTs analyzed included a PROM as a primary outcome.

Meaning  This systematic review found that PROMs often were not included in acne and rosacea RCTs and were rarely included as a primary outcome measure; increasing inclusion of patient-centered outcomes in RCTs can ensure that the patient’s perspective is captured during development of new treatments, and research is needed on improving incorporation of PROMs in RCTs.

Abstract

Importance  Acne and rosacea have substantial implications for quality of life, and it is therefore important to ensure the patient’s voice is being captured in pivotal randomized clinical trials (RCTs). Although patient-reported outcome measures (PROMs) are a valuable tool to capture the patient perspective, little is known about use of PROMs in RCTs on acne and rosacea.

Objective  To characterize the use of PROMs in RCTs on acne and rosacea.

Evidence Review  A systematic literature search was conducted using the search terms acne vulgaris and rosacea in the following databases: MEDLINE through PubMed, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. A modified search hedge for RCTs from the McGill Library was applied. All phase 2, 3, and 4 RCTs published between December 31, 2011, through December 31, 2021, that evaluated the efficacy and safety of therapies for acne and rosacea vs any comparator were eligible for inclusion.

Findings  A total of 2461 publications describing RCTs were identified, of which 206 RCTs met the inclusion criteria (163 trials [79%] on acne and 43 [21%] on rosacea). At least 1 PROM was used in 53% of trials (110) included; PROM use was more common in rosacea RCTs (67% [n = 29]) compared with acne RCTs (50% [n = 81]). At least 1 dermatology-specific (13% [n = 27]) or disease-specific (14% [n = 28]) PROM was included in the RCTs analyzed. Only 7% of trials (14) included a PROM as a primary outcome measure. There was no statistically significant increase in PROM inclusion over the study period (11 of 21 trials in 2011 vs 5 of 12 trials in 2021).

Conclusions and Relevance  In this systematic review, PROMs were included in approximately one-half of acne and rosacea RCTs performed over the study period. In addition, PROMs were rarely used as a primary outcome measure, and inclusion of PROMs has not increased substantially over the past 10 years. Increasing use of PROMs in RCTs can ensure that the patient’s perspective is captured during the development of new treatments for acne and rosacea.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: July 26, 2022.

Published Online: October 26, 2022. doi:10.1001/jamadermatol.2022.3911

Corresponding Author: John S. Barbieri, MD, MBA, Department of Dermatology, Brigham and Women’s Hospital, 41 Avenue Louis Pasteur, Boston, MA 02115 (jbarbieri@bwh.harvard.edu).

Author Contributions: Ms Ly and Mr Miller had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Ms Ly and Mr Miller contributed equally to this study.

Concept and design: Ly, Miller, Mostaghimi, Barbieri.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Ly, Miller, Tong, Blake, Barbieri.

Critical revision of the manuscript for important intellectual content: Ly, Miller, Mostaghimi, Barbieri.

Statistical analysis: Ly, Miller, Barbieri.

Administrative, technical, or material support: Miller, Blake, Mostaghimi.

Supervision: Mostaghimi, Barbieri.

Conflict of Interest Disclosures: Dr Mostaghimi reported receiving personal fees from hims & hers, Figure Co, ACOM, Digital Diagnostics, Concert, Pfizer, Eli Lilly and Company, AbbVie, Equillium, and Boehringer Ingelheim outside the submitted work; and serves as an Associate Editor for JAMA Dermatology. Dr Barbieri serves as an Associate Editor for JAMA Dermatology. No other disclosures were reported.

Disclaimer: Drs Mostaghimi and Barbieri are Associate Editors of JAMA Dermatology but were not involved in any of the decisions regarding review of the manuscript or its acceptance.

References
1.
Barbieri  JS , Fulton  R , Neergaard  R , Nelson  MN , Barg  FK , Margolis  DJ .  Patient perspectives on the lived experience of acne and its treatment among adult women with acne: a qualitative study.   JAMA Dermatol. 2021;157(9):1040-1046. doi:10.1001/jamadermatol.2021.2185 PubMedGoogle ScholarCrossref
2.
Abram  K , Silm  H , Maaroos  HI , Oona  M .  Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea.   Acta Derm Venereol. 2009;89(5):488-491. doi:10.2340/00015555-0716 PubMedGoogle ScholarCrossref
3.
Stuart  B , Maund  E , Wilcox  C ,  et al.  Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis.   Br J Dermatol. 2021;185(3):512-525. doi:10.1111/bjd.20080 PubMedGoogle ScholarCrossref
4.
Gnanasakthy  A , Mordin  M , Evans  E , Doward  L , DeMuro  C .  A review of patient-reported outcome labeling in the United States (2011-2015).   Value Health. 2017;20(3):420-429. doi:10.1016/j.jval.2016.10.006 PubMedGoogle ScholarCrossref
5.
Townshend  AP , Chen  CM , Williams  HC .  How prominent are patient-reported outcomes in clinical trials of dermatological treatments?   Br J Dermatol. 2008;159(5):1152-1159. doi:10.1111/j.1365-2133.2008.08799.x PubMedGoogle ScholarCrossref
6.
Schmitt  J , Deckert  S , Alam  M ,  et al.  Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).   Br J Dermatol. 2016;174(2):287-295. doi:10.1111/bjd.14337 PubMedGoogle ScholarCrossref
7.
Perez-Chada  L , Taliercio  VL , Gottlieb  A ,  et al.  Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders: on behalf of International Dermatology Outcome Measures and the American Academy of Dermatology.   J Am Acad Dermatol. 2019;S0190-9622(19):32745-32748. doi:10.1016/j.jaad.2019.09.008 PubMedGoogle ScholarCrossref
8.
Resneck  JS  Jr , VanBeek  M .  What dermatology still needs to create meaningful patient outcome measurements.   JAMA Dermatol. 2015;151(4):371-372. doi:10.1001/jamadermatol.2014.3514 PubMedGoogle ScholarCrossref
9.
Agency for Healthcare Research and Quality. Types of health care quality measures. Published 2011. https://www.ahrq.gov/talkingquality/measures/types.html. Accessed April 22, 2021.
10.
Copley-Merriman  C , Zelt  S , Clark  M , Gnanasakthy  A .  Impact of measuring patient-reported outcomes in dermatology drug development.   Patient. 2017;10(2):203-213. doi:10.1007/s40271-016-0196-6 PubMedGoogle ScholarCrossref
11.
Lefebvre  C , Glanville  J , Briscoe  S ,  et al. Chapter 4: searching for and selecting studies. In: Higgins  JPT , Thomas  J , Chandler  J ,  et al, eds.  Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane; 2022. Accessed August 15, 2022. https://training.cochrane.org/handbook/current/chapter-04
12.
Page  MJ , McKenzie  JE , Bossuyt  PM ,  et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.   BMJ. 2021;372(71):n71. doi:10.1136/bmj.n71 PubMedGoogle ScholarCrossref
13.
Baumann  L , Goldberg  DJ , Stein Gold  L ,  et al.  Pivotal trial of the efficacy and safety of oxymetazoline cream 1.0% for the treatment of persistent facial erythema associated with rosacea: findings from the second REVEAL trial.   J Drugs Dermatol. 2018;17(3):290-298.PubMedGoogle Scholar
14.
Bribeche  MR , Fedotov  VP , Gladichev  VV , Pukhalskaya  DM , Kolitcheva  NL .  Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea.   Int J Dermatol. 2015;54(4):481-487. doi:10.1111/ijd.12552 PubMedGoogle ScholarCrossref
15.
Cao  T , Tan  ES , Chan  YH , Yosipovitch  G , Tey  HL .  Anti-pruritic efficacies of doxycycline and erythromycin in the treatment of acne vulgaris: a randomized single-blinded pilot study.   Indian J Dermatol Venereol Leprol. 2018;84(4):458-460. doi:10.4103/ijdvl.IJDVL_41_17 PubMedGoogle ScholarCrossref
16.
Chilicka  K , Rogowska  AM , Szyguła  R , Taradaj  J .  Examining quality of life after treatment with azelaic and pyruvic acid peels in women with acne vulgaris.   Clin Cosmet Investig Dermatol. 2020;13:469-477. doi:10.2147/CCID.S262691 PubMedGoogle ScholarCrossref
17.
Fowler  J , Jarratt  M , Moore  A ,  et al; Brimonidine Phase II Study Group.  Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.   Br J Dermatol. 2012;166(3):633-641. doi:10.1111/j.1365-2133.2011.10716.x PubMedGoogle ScholarCrossref
18.
Kircik  LH , DuBois  J , Draelos  ZD ,  et al.  Pivotal trial of the efficacy and safety of oxymetazoline cream 1.0% for the treatment of persistent facial erythema associated with rosacea: findings from the first REVEAL trial.   J Drugs Dermatol. 2018;17(1):97-105.PubMedGoogle Scholar
19.
Layton  AM , Schaller  M , Homey  B ,  et al.  Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.   J Eur Acad Dermatol Venereol. 2015;29(12):2405-2410. doi:10.1111/jdv.13305 PubMedGoogle ScholarCrossref
20.
Luger  T , Peukert  N , Rother  M .  A multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea.   J Eur Acad Dermatol Venereol. 2015;29(2):283-290. doi:10.1111/jdv.12520 PubMedGoogle ScholarCrossref
21.
Mohammadi  S , Badakhsh  H , Pardakhti  A ,  et al.  Evaluation of efficacy of niosomal clindamycin phosphate 1% solution in comparison to conventional clindamycin phosphate 1% solution in the treatment of acne vulgaris: a randomized controlled trial.   J Pak Assoc Dermatol. 2020;30(1):64-71.Google Scholar
22.
Rocha  M , Sanudo  A , Bagatin  E .  The effect on acne quality of life of topical azelaic acid 15% gel versus a combined oral contraceptive in adult female acne: a randomized trial.   Dermatoendocrinol. 2017;9(1):e1361572. doi:10.1080/19381980.2017.1361572 PubMedGoogle ScholarCrossref
23.
Schlessinger  J , Lupin  M , McDaniel  D , George  R .  Safety and effectiveness of microfocused ultrasound for treating erythematotelangiectatic rosacea.   J Drugs Dermatol. 2019;18(6):522.PubMedGoogle Scholar
24.
Taieb  A , Passeron  T , Ruzicka  T ,  et al.  Ivermectin cream improves health-related quality of life in patients with rosacea: data from a randomized trial.   Br J Dermatol. 2016;175(6):1366-1368. doi:10.1111/bjd.14665 PubMedGoogle ScholarCrossref
25.
van der Linden  MMD , van Ratingen  AR , van Rappard  DC , Nieuwenburg  SA , Spuls  PI .  DOMINO, doxycycline 40 mg vs minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety.   Br J Dermatol. 2017;176(6):1465-1474. doi:10.1111/bjd.15155 PubMedGoogle ScholarCrossref
26.
Schaller  M , Kemény  L , Havlickova  B ,  et al.  A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.   J Am Acad Dermatol. 2020;82(2):336-343. doi:10.1016/j.jaad.2019.05.063PubMedGoogle ScholarCrossref
27.
Brodell  R , Wertheimer  A , Toth  D ,  et al.  Treatment with adapalene-benzoyl peroxide improve quality of life in patients with severe acne vulgaris.   J Am Acad Dermatol. 2013;68(4):AB19. doi:10.1016/j.jaad.2012.12.082Google ScholarCrossref
28.
Seo  HM , Kim  JI , Kim  HS , Choi  YJ , Kim  WS .  Prospective comparison of dual wavelength long-pulsed 755-nm alexandrite/1,064-nm neodymium:yttrium-aluminum-garnet laser versus 585-nm pulsed dye laser treatment for rosacea.   Ann Dermatol. 2016;28(5):607-614. doi:10.5021/ad.2016.28.5.607PubMedGoogle ScholarCrossref
29.
Gold  LS , Del Rosso  JQ , Kircik  L ,  et al.  Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.   J Am Acad Dermatol. 2020;82(5):1166-1173. doi:10.1016/j.jaad.2020.01.043PubMedGoogle ScholarCrossref
30.
Gold  LS , Dhawan  S , Weiss  J , Draelos  ZD , Ellman  H , Stuart  IA .  A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.   J Am Acad Dermatol. 2019;80(1):168-177. doi:10.1016/j.jaad.2018.08.020PubMedGoogle ScholarCrossref
31.
Tan  J , Thiboutot  D , Popp  G ,  et al.  Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.   J Am Acad Dermatol. 2019;80(6):1691-1699. doi:10.1016/j.jaad.2019.02.044PubMedGoogle ScholarCrossref
32.
Raoof  TJ , Hooper  D , Moore  A ,  et al.  Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.   J Am Acad Dermatol. 2020;82(4):832-837. doi:10.1016/j.jaad.2019.05.078PubMedGoogle ScholarCrossref
33.
Bissonnette  R , Poulin  Y , Drew  J , Hofland  H , Tan  J .  Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study.   J Am Acad Dermatol. 2017;76(1):33-39. doi:10.1016/j.jaad.2016.08.053PubMedGoogle ScholarCrossref
34.
Di Nardo  A , Holmes  AD , Muto  Y ,  et al.  Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial.   J Am Acad Dermatol. 2016;74(6):1086-1092. doi:10.1016/j.jaad.2016.01.023PubMedGoogle ScholarCrossref
35.
Shemer  A , Shiri  J , Mashiah  J , Farhi  R , Gupta  AK .  Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.   J Am Acad Dermatol. 2016;74(6):1251-1252. doi:10.1016/j.jaad.2015.09.065PubMedGoogle ScholarCrossref
36.
Hebert  A , Thiboutot  D , Stein Gold  L ,  et al.  Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials.   JAMA Dermatol. 2020;156(6):621-630. doi:10.1001/jamadermatol.2020.0465PubMedGoogle ScholarCrossref
37.
Dréno  B , Kaufmann  R , Talarico  S ,  et al.  Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.   Br J Dermatol. 2011;165(2):383-390. doi:10.1111/j.1365-2133.2011.10374.xPubMedGoogle ScholarCrossref
38.
Kwon  HH , Lee  JB , Yoon  JY ,  et al.  The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial.   Br J Dermatol. 2013;168(5):1088-1094. doi:10.1111/bjd.12186PubMedGoogle ScholarCrossref
39.
Webster  G , Draelos  ZD , Graber  E ,  et al.  A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea.   Br J Dermatol. 2020;183(3):471-479. doi:10.1111/bjd.18857PubMedGoogle ScholarCrossref
40.
Poulin  Y , Sanchez  NP , Bucko  A ,  et al.  A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial.   Br J Dermatol. 2011;164(6):1376-1382. doi:10.1111/j.1365-2133.2011.10344.xPubMedGoogle ScholarCrossref
41.
Pariser  DM , Eichenfield  LF , Bukhalo  M , Waterman  G , Jarratt  M ; PDT Study Group.  Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.   Br J Dermatol. 2016;174(4):770-777. doi:10.1111/bjd.14345PubMedGoogle ScholarCrossref
42.
Taieb  A , Ortonne  JP , Ruzicka  T ,  et al; Ivermectin Phase III study group.  Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.   Br J Dermatol. 2015;172(4):1103-1110. doi:10.1111/bjd.13408PubMedGoogle ScholarCrossref
43.
Tan  J , Humphrey  S , Vender  R ,  et al; POWER study group.  A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.   Br J Dermatol. 2014;171(6):1508-1516. doi:10.1111/bjd.13191PubMedGoogle ScholarCrossref
44.
Kawashima  M , Hashimoto  H , Alió Sáenz  AB , Ono  M , Yamada  M .  Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.   Br J Dermatol. 2015;172(2):494-503. doi:10.1111/bjd.13265PubMedGoogle ScholarCrossref
45.
Trifu  V , Tiplica  GS , Naumescu  E , Zalupca  L , Moro  L , Celasco  G .  Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.   Br J Dermatol. 2011;165(1):177-183. doi:10.1111/j.1365-2133.2011.10332.xPubMedGoogle ScholarCrossref
46.
Paithankar  DY , Sakamoto  FH , Farinelli  WA ,  et al.  Acne treatment based on selective photothermolysis of sebaceous follicles with topically delivered light-absorbing gold microparticles.   J Invest Dermatol. 2015;135(7):1727-1734. doi:10.1038/jid.2015.89PubMedGoogle ScholarCrossref
47.
Stein Gold  L , Weiss  J , Rueda  MJ , Liu  H , Tanghetti  E .  Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3 %/benzoyl peroxide 2.5 % gel: a randomized, double-blind, parallel-group, controlled study.   Am J Clin Dermatol. 2016;17(3):293-303. doi:10.1007/s40257-016-0178-4PubMedGoogle ScholarCrossref
48.
Stein Gold  L , Baldwin  H , Kircik  LH ,  et al.  Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug.   Am J Clin Dermatol. 2022;23(1):93-104. doi:10.1007/s40257-021-00650-3PubMedGoogle ScholarCrossref
49.
Mrowietz  U , Kedem  TH , Keynan  R ,  et al.  A phase II, randomized, double-blind clinical study evaluating the safety, tolerability, and efficacy of a topical minocycline foam, FMX103, for the treatment of facial papulopustular rosacea.   Am J Clin Dermatol. 2018;19(3):427-436. doi:10.1007/s40257-017-0339-0PubMedGoogle ScholarCrossref
50.
Tomić  I , Miočić  S , Pepić  I , Šimić  D , Filipović-Grčić  J .  Efficacy and safety of azelaic acid nanocrystal-loaded in situ hydrogel in the treatment of acne vulgaris.   Pharmaceutics. 2021;13(4):567. doi:10.3390/pharmaceutics13040567PubMedGoogle ScholarCrossref
51.
Thielitz  A , Lux  A , Wiede  A , Kropf  S , Papakonstantinou  E , Gollnick  H .  A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne.   J Eur Acad Dermatol Venereol. 2015;29(4):789-796. doi:10.1111/jdv.12823PubMedGoogle ScholarCrossref
52.
Babayeva  L , Akarsu  S , Fetil  E , Güneş  AT .  Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris.   J Eur Acad Dermatol Venereol. 2011;25(3):328-333. doi:10.1111/j.1468-3083.2010.03793.xPubMedGoogle ScholarCrossref
53.
Bouloc  A , Roo  E , Imko-Walczuk  B , Moga  A , Chadoutaud  B , Dréno  B .  A skincare combined with combination of adapalene and benzoyl peroxide provides a significant adjunctive efficacy and local tolerance benefit in adult women with mild acne.   J Eur Acad Dermatol Venereol. 2017;31(10):1727-1731. doi:10.1111/jdv.14379PubMedGoogle ScholarCrossref
54.
Xu  JH , Lu  QJ , Huang  JH ,  et al.  A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.   J Eur Acad Dermatol Venereol. 2016;30(7):1176-1182. doi:10.1111/jdv.13622PubMedGoogle ScholarCrossref
55.
Schaller  M , Sebastian  M , Ress  C , Seidel  D , Hennig  M .  A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.   J Eur Acad Dermatol Venereol. 2016;30(6):966-973. doi:10.1111/jdv.13541PubMedGoogle ScholarCrossref
56.
Guo  K , Zhu  D , Lu  Z , Pan  Y , Deng  H .  Effect of minocycline hydrochloride combined with photodynamic therapy on skin barrier function of patients with acne.   Am J Transl Res. 2021;13(7):8427-8432.PubMedGoogle Scholar
57.
Ibrahim  SM , Farag  A , Hegazy  R , Mongy  M , Shalaby  S , Kamel  MM .  Combined low-dose isotretinoin and pulsed dye laser versus standard-dose isotretinoin in the treatment of inflammatory acne.   Lasers Surg Med. 2021;53(5):603-609. doi:10.1002/lsm.23356PubMedGoogle ScholarCrossref
58.
Ahn  GR , Kim  JM , Park  SJ , Li  K , Kim  BJ .  Selective sebaceous gland electrothermolysis using a single microneedle radiofrequency device for acne patients: a prospective randomized controlled study.   Lasers Surg Med. 2020;52(5):396-401. doi:10.1002/lsm.23152PubMedGoogle ScholarCrossref
59.
Wu  HE , Liu  YB , Cui  L , Xu  GJ , Sun  XD .  Three-step irradiance schedule versus two-step irradiance schedule for pain control during topical 5-aminolevulinic acid-photodynamic therapy of facial acne in Chinese patients: a prospective randomized comparative study.   Lasers Surg Med. 2022;54(2):224-229. doi:10.1002/lsm.23464PubMedGoogle ScholarCrossref
60.
Nitayavardhana  S , Manuskiatti  W , Cembrano  KAG , Wanitphadeedecha  R .  A comparative study between once-weekly and alternating twice-weekly regimen using blue (470 nm) and red (640 nm) light combination led phototherapy for moderate-to-severe acne vulgaris.   Lasers Surg Med. 2021;53(8):1080-1085. doi:10.1002/lsm.23388PubMedGoogle ScholarCrossref
61.
Hayashi  N , Kurokawa  I , Siakpere  O ,  et al.  Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.   J Dermatol. 2018;45(8):951-962. doi:10.1111/1346-8138.14497PubMedGoogle ScholarCrossref
62.
Chottawornsak  N , Chongpison  Y , Asawanonda  P , Kumtornrut  C .  Topical 2% ketoconazole cream monotherapy significantly improves adult female acne: A double-blind, randomized placebo-controlled trial.   J Dermatol. 2019;46(12):1184-1189. doi:10.1111/1346-8138.15113PubMedGoogle ScholarCrossref
63.
Miyachi  Y , Yamasaki  K , Fujita  T , Fujii  C .  Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.   J Dermatol. 2022;49(3):330-340. doi:10.1111/1346-8138.16254PubMedGoogle ScholarCrossref
64.
Akarsu  S , Fetil  E , Yücel  F , Gül  E , Güneş  AT .  Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.   J Dermatol. 2012;39(5):433-438. doi:10.1111/j.1346-8138.2011.01405.xPubMedGoogle ScholarCrossref
65.
Kwon  HH , Moon  KR , Park  SY , Yoon  JY , Suh  DH , Lee  JB .  Daylight photodynamic therapy with 1.5% 3-butenyl 5-aminolevulinate gel as a convenient, effective and safe therapy in acne treatment: A double-blind randomized controlled trial.   J Dermatol. 2016;43(5):515-521. doi:10.1111/1346-8138.13191PubMedGoogle ScholarCrossref
66.
Patiyasikunt  M , Chancheewa  B , Asawanonda  P , Noppakun  N , Kumtornrut  C .  Efficacy and tolerability of low-dose spironolactone and topical benzoyl peroxide in adult female acne: A randomized, double-blind, placebo-controlled trial.   J Dermatol. 2020;47(12):1411-1416. doi:10.1111/1346-8138.15559PubMedGoogle ScholarCrossref
67.
Kawashima  M , Sato  S , Furukawa  F ,  et al.  Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.   J Dermatol. 2017;44(7):774-782. doi:10.1111/1346-8138.13798PubMedGoogle ScholarCrossref
68.
Kawashima  M , Hashimoto  H , Alio Sáenz  AB , Ono  M , Yamada  M .  Is benzoyl peroxide 3% topical gel effective and safe in the treatment of acne vulgaris in Japanese patients? A multicenter, randomized, double-blind, vehicle-controlled, parallel-group study.   J Dermatol. 2014;41(9):795-801. doi:10.1111/1346-8138.12580PubMedGoogle ScholarCrossref
69.
Kobayashi  M , Nakagawa  T , Fukamachi  K , Nakamura  M , Tokura  Y .  Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.   J Dermatol. 2011;38(12):1163-1166. doi:10.1111/j.1346-8138.2011.01280.xPubMedGoogle ScholarCrossref
70.
Pazoki-Toroudi  H , Nilforoushzadeh  MA , Ajami  M ,  et al.  Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.   Cutan Ocul Toxicol. 2011;30(4):286-291. doi:10.3109/15569527.2011.581257PubMedGoogle ScholarCrossref
71.
Serdar  ZA , Yaşar  Ş .  Efficacy of 1% terbinafine cream in comparison with 0.75% metronidazole gel for the treatment of papulopustular rosacea.   Cutan Ocul Toxicol. 2011;30(2):124-128. doi:10.3109/15569527.2010.541398PubMedGoogle ScholarCrossref
72.
Zhang  L , Zhang  Y , Liu  X ,  et al.  Conventional versus daylight photodynamic therapy for acne vulgaris: A randomized and prospective clinical study in China.   Photodiagnosis Photodyn Ther. 2020;31:101796. doi:10.1016/j.pdpdt.2020.101796PubMedGoogle ScholarCrossref
73.
Mohammadi  S , Pardakhty  A , Khalili  M ,  et al.  Niosomal benzoyl peroxide and clindamycin lotion versus niosomal clindamycin lotion in treatment of acne vulgaris: a randomized clinical trial.   Adv Pharm Bull. 2019;9(4):578-583. doi:10.15171/apb.2019.066PubMedGoogle ScholarCrossref
74.
Luo  Y , Luan  XL , Zhang  JH , Wu  LX , Zhou  N .  Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm-wavelength intense pulsed light: A prospective randomized controlled trial with a 2-year follow-up.   Exp Ther Med. 2020;19(6):3543-3550. doi:10.3892/etm.2020.8617PubMedGoogle ScholarCrossref
75.
Bae  BG , Park  CO , Shin  H ,  et al.  Salicylic acid peels versus Jessner’s solution for acne vulgaris: a comparative study.   Dermatol Surg. 2013;39(2):248-253. doi:10.1111/dsu.12018PubMedGoogle ScholarCrossref
76.
Abdel Meguid  AM , Elaziz Ahmed Attallah  DA , Omar  H .  Trichloroacetic acid versus salicylic acid in the treatment of acne vulgaris in dark-skinned patients.   Dermatol Surg. 2015;41(12):1398-1404. doi:10.1097/DSS.0000000000000522PubMedGoogle ScholarCrossref
77.
Jaisamrarn  U , Chaovisitsaree  S , Angsuwathana  S , Nerapusee  O .  A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial.   Contraception. 2014;90(5):535-541. doi:10.1016/j.contraception.2014.06.002PubMedGoogle ScholarCrossref
78.
Kubota  Y , Munehiro  A , Shirahige  Y ,  et al.  Effect of sequential application of topical adapalene and clindamycin phosphate in the treatment of Japanese patients with acne vulgaris.   J Dermatolog Treat. 2012;23(1):37-45. doi:10.3109/09546634.2010.519016PubMedGoogle ScholarCrossref
79.
Brodell  RT , Schlosser  BJ , Rafal  E ,  et al.  A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.   J Dermatolog Treat. 2012;23(1):26-34. doi:10.3109/09546634.2011.643221PubMedGoogle ScholarCrossref
80.
Abdel Hay  R , Hegazy  R , Abdel Hady  M , Saleh  N .  Clinical and dermoscopic evaluation of combined (salicylic acid 20% and azelaic acid 20%) versus trichloroacetic acid 25% chemical peel in acne: an RCT.   J Dermatolog Treat. 2019;30(6):572-577. doi:10.1080/09546634.2018.1484876PubMedGoogle ScholarCrossref
81.
Dogra  S , Sumathy  TK , Nayak  C ,  et al.  Efficacy and safety comparison of combination of 0.04% tretinoin microspheres plus 1% clindamycin versus their monotherapy in patients with acne vulgaris: a phase 3, randomized, double-blind study.   J Dermatolog Treat. 2021;32(8):925-933. doi:10.1080/09546634.2020.1720579PubMedGoogle ScholarCrossref
82.
Shen  WT , Wu  Y , He  HQ ,  et al.  Efficacy and safety of artemether emulsion for the treatment of mild-to-moderate acne vulgaris: a randomized pilot study.   J Dermatolog Treat. 2021;32(7):762-765. doi:10.1080/09546634.2019.1710447PubMedGoogle ScholarCrossref
83.
Sayyafan  MS , Ramzi  M , Salmanpour  R .  Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris.   J Dermatolog Treat. 2020;31(7):730-733. doi:10.1080/09546634.2019.1606394PubMedGoogle ScholarCrossref
84.
Chularojanamontri  L , Tuchinda  P , Kulthanan  K , Varothai  S , Winayanuwattikun  W .  A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel.   J Dermatolog Treat. 2016;27(2):140-145. doi:10.3109/09546634.2015.1079298PubMedGoogle ScholarCrossref
85.
Lee  HE , Ko  JY , Kim  YH ,  et al.  A double-blind randomized controlled comparison of APDDR-0901, a novel cosmeceutical formulation, and 0.1% adapalene gel in the treatment of mild-to-moderate acne vulgaris.   Eur J Dermatol. 2011;21(6):959-965. doi:10.1684/ejd.2011.1546PubMedGoogle ScholarCrossref
86.
Tan  J , Bissonnette  R , Gratton  D , Kerrouche  N , Canosa  JM .  The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.   Eur J Dermatol. 2018;28(4):502-508. doi:10.1684/ejd.2018.3367PubMedGoogle ScholarCrossref
87.
Dréno  B , Bettoli  V , Ochsendorf  F ,  et al.  Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies.   Eur J Dermatol. 2014;24(2):201-209. doi:10.1684/ejd.2014.2293PubMedGoogle ScholarCrossref
88.
Liu  LH , Fan  X , An  YX , Zhang  J , Wang  CM , Yang  RY .  Randomized trial of three phototherapy methods for the treatment of acne vulgaris in Chinese patients.   Photodermatol Photoimmunol Photomed. 2014;30(5):246-253. doi:10.1111/phpp.12098PubMedGoogle ScholarCrossref
89.
Lim  SK , Ha  JM , Lee  YH ,  et al.  Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled trial.   PLoS One. 2016;11(8):e0161162. doi:10.1371/journal.pone.0161162PubMedGoogle ScholarCrossref
90.
Li  Y , Zhu  J , Zhang  Y , Liu  X , Ye  J .  Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: a randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects.   Lasers Med Sci. 2021;36(3):657-665. doi:10.1007/s10103-020-03113-zPubMedGoogle ScholarCrossref
91.
El-Latif  AAA , Hassan  FAA , Elshahed  AR , Mohamed  AG , Elsaie  ML .  Intense pulsed light versus benzoyl peroxide 5% gel in treatment of acne vulgaris.   Lasers Med Sci. 2014;29(3):1009-1015. doi:10.1007/s10103-013-1440-0PubMedGoogle ScholarCrossref
92.
Kim  TI , Ahn  HJ , Kang  IH , Jeong  KH , Kim  NI , Shin  MK .  Nonablative fractional laser-assisted daylight photodynamic therapy with topical methyl aminolevulinate for moderate to severe facial acne vulgaris: Results of a randomized and comparative study.   Photodermatol Photoimmunol Photomed. 2017;33(5):253-259. doi:10.1111/phpp.12312PubMedGoogle ScholarCrossref
93.
Nicklas  C , Rubio  R , Cárdenas  C , Hasson  A .  Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial.   Photodermatol Photoimmunol Photomed. 2019;35(1):3-10. doi:10.1111/phpp.12413PubMedGoogle ScholarCrossref
94.
Mei  X , Shi  W , Piao  Y .  Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light in Chinese acne vulgaris patients.   Photodermatol Photoimmunol Photomed. 2013;29(2):90-96. doi:10.1111/phpp.12031PubMedGoogle ScholarCrossref
95.
Jaisamrarn  U , Santibenchakul  S .  A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial.   Contracept Reprod Med. 2018;3(1):5. doi:10.1186/s40834-018-0058-9PubMedGoogle ScholarCrossref
96.
Morganti  P , Berardesca  E , Guarneri  B ,  et al.  Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial.   Int J Cosmet Sci. 2011;33(5):467-476. doi:10.1111/j.1468-2494.2011.00658.xPubMedGoogle ScholarCrossref
97.
Bertolani  MB , Rodighiero  E , Gandolfi  M ,  et al.  Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study.   Dermatol Ther. 2021;34(1):e14724. doi:10.1111/dth.14724PubMedGoogle ScholarCrossref
98.
Cameli  N , Mariano  M , Zanniello  R , Berardesca  E .  Clinical and noninvasive instrumental evaluation of the efficacy of a nonsteroidal anti-inflammatory 8-beta glycyrrhetinic acid cream for the treatment of erythema in rosacea.   Dermatol Ther. 2020;33(6):e14224. doi:10.1111/dth.14224PubMedGoogle ScholarCrossref
99.
Shie Morteza  M , Hayati  Z , Namazi  N , Abdollahimajd  F .  Efficacy and safety of oral silymarin in comparison with oral doxycycline and their combination therapy in the treatment of acne vulgaris.   Dermatol Ther. 2019;32(6):e13095. doi:10.1111/dth.13095PubMedGoogle ScholarCrossref
100.
Al-Sudany  NK , Mohammed  NH , Alrifai  SB .  Downregulation of S100a7a antimicrobial peptide in acne vulgaris patients after isotretinoin therapy.   Dermatol Ther. 2019;32(6):e13136. doi:10.1111/dth.13136PubMedGoogle ScholarCrossref
101.
Son  BK , Yun  Y , Choi  IH .  Efficacy of ah shi point acupuncture on acne vulgaris.   Acupunct Med. 2010;28(3):126-129. doi:10.1136/aim.2010.003004PubMedGoogle ScholarCrossref
102.
Bamford  JTM , Gessert  CE , Haller  IV , Kruger  K , Johnson  BP .  Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea.   Int J Dermatol. 2012;51(4):459-462. doi:10.1111/j.1365-4632.2011.05353.xPubMedGoogle ScholarCrossref
103.
Chan  H , Chan  G , Santos  J , Dee  K , Co  JK .  A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris.   Int J Dermatol. 2017;56(6):686-690. doi:10.1111/ijd.13607PubMedGoogle ScholarCrossref
104.
Khodaeiani  E , Fouladi  RF , Amirnia  M , Saeidi  M , Karimi  ER .  Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.   Int J Dermatol. 2013;52(8):999-1004. doi:10.1111/ijd.12002PubMedGoogle ScholarCrossref
105.
Guertler  A , Jøntvedt  NM , Clanner-Engelshofen  BM , Cappello  C , Sager  A , Reinholz  M .  Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.   J Cosmet Dermatol. 2020;19(10):2627-2633. doi:10.1111/jocd.13591PubMedGoogle ScholarCrossref
106.
Zayed  AA , Sobhi  RM , El Aguizy  RMS , Sabry  D , Mahmoud  SB .  Sequential peeling as a monotherapy for treatment of milder forms of acne vulgaris.   J Cosmet Dermatol. 2020;19(6):1381-1387. doi:10.1111/jocd.13162PubMedGoogle ScholarCrossref
107.
Kumtornrut  C , Manabe  SD , Navapongsiri  M ,  et al.  A cleanser formulated with Tris (hydroxymethyl) aminomethane and l-arginine significantly improves facial acne in male Thai subjects.   J Cosmet Dermatol. 2020;19(4):901-909. doi:10.1111/jocd.13087PubMedGoogle ScholarCrossref
108.
Abels  C , Kaszuba  A , Michalak  I , Werdier  D , Knie  U , Kaszuba  A .  A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial.   J Cosmet Dermatol. 2011;10(3):202-209. doi:10.1111/j.1473-2165.2011.00572.xPubMedGoogle ScholarCrossref
109.
Lee  HJ , Kim  JY , Park  KD , Lee  WJ .  Randomized controlled double-blind study of a cleanser composed of 5-aminolevulinic acid and peptides on mild and moderate acne vulgaris.   J Cosmet Dermatol. 2020;19(7):1745-1750. doi:10.1111/jocd.13232PubMedGoogle ScholarCrossref
110.
Rokni  GR , Mohammadnezhad  F , Saeedi  M ,  et al.  Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single-blinded, active-controlled trial.   J Cosmet Dermatol. 2021;20(11):3580-3585. doi:10.1111/jocd.14462PubMedGoogle ScholarCrossref
111.
Monib  KME , Hussein  MS .  Nd:YAG laser vs IPL in inflammatory and noninflammatory acne lesion treatment.   J Cosmet Dermatol. 2020;19(9):2325-2332. doi:10.1111/jocd.13278PubMedGoogle ScholarCrossref
112.
Cestone  E , Michelotti  A , Zanoletti  V , Zanardi  A , Mantegazza  R , Dossena  M .  Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study.   J Cosmet Dermatol. 2017;16(2):265-270. doi:10.1111/jocd.12309PubMedGoogle ScholarCrossref
113.
Draelos  ZD , Ertel  K , Rom  D .  Five-day study to judge the short-term effect of a benzoyl peroxide 3% gel on acne lesions.   J Cosmet Dermatol. 2016;15(4):350-357. doi:10.1111/jocd.12251PubMedGoogle ScholarCrossref
114.
Dayal  S , Kalra  KD , Sahu  P .  Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris.   J Cosmet Dermatol. 2020;19(2):393-399. doi:10.1111/jocd.13168PubMedGoogle ScholarCrossref
115.
Dayal  S , Amrani  A , Sahu  P , Jain  VK .  Jessner’s solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild-to-moderate acne vulgaris.   J Cosmet Dermatol. 2017;16(1):43-51. doi:10.1111/jocd.12266PubMedGoogle ScholarCrossref
116.
Tirado-Sánchez  A , Espíndola  YS , Ponce-Olivera  RM , Bonifaz  A .  Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).   J Cosmet Dermatol. 2013;12(2):103-107. doi:10.1111/jocd.12031PubMedGoogle ScholarCrossref
117.
Agarwal  US , Besarwal  RK , Bhola  K .  Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial.   Indian J Dermatol Venereol Leprol. 2011;77(6):688-694. doi:10.4103/0378-6323.86482PubMedGoogle ScholarCrossref
118.
Luo  Y , Luan  XL , Sun  YJ , Zhang  L , Zhang  JH .  Effect of recombinant bovine basic fibroblast growth factor gel on repair of rosacea skin lesions: A randomized, single-blind and vehicle-controlled study.   Exp Ther Med. 2019;17(4):2725-2733. doi:10.3892/etm.2019.7258PubMedGoogle ScholarCrossref
119.
Babaeinejad  S , Khodaeiani  E , Fouladi  RF .  Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age?   J Dermatolog Treat. 2011;22(4):206-210. doi:10.3109/09546631003762639PubMedGoogle ScholarCrossref
120.
Ianosi  S , Neagoe  D , Calbureanu  M , Ianosi  G .  Investigator-blind, placebo-controlled, randomized comparative study on combined vacuum and intense pulsed light versus intense pulsed light devices in both comedonal and papulopustular acne.   J Cosmet Laser Ther. 2013;15(5):248-254. doi:10.3109/14764172.2013.814464PubMedGoogle ScholarCrossref
121.
Dayal  S , Singh  S , Sahu  P .  Efficacy and safety of 25% trichloroacetic acid peel versus 30% salicylic acid peel in mild-to-moderate acne vulgaris: a comparative study.   Dermatol Pract Concept. 2021;11(3):e2021063. doi:10.5826/dpc.1103a63PubMedGoogle ScholarCrossref
122.
Xu  X , Zheng  Y , Zhao  Z , Zhang  X , Liu  P , Li  C .  Efficacy of photodynamic therapy combined with minocycline for treatment of moderate to severe facial acne vulgaris and influence on quality of life.   Medicine (Baltimore). 2017;96(51):e9366. doi:10.1097/MD.0000000000009366PubMedGoogle ScholarCrossref
123.
Jaffary  F , Faghihi  G , Saraeian  S , Hosseini  SM .  Comparison the effectiveness of pyruvic acid 50% and salicylic acid 30% in the treatment of acne.   J Res Med Sci. 2016;21(2):31. doi:10.4103/1735-1995.181991PubMedGoogle ScholarCrossref
124.
Shahmoradi  Z , Iraji  F , Siadat  AH , Ghorbaini  A .  Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial.   J Res Med Sci. 2013;18(2):115-117.PubMedGoogle Scholar
125.
Eichenfield  LF , Hebert  AA , Schachner  L , Paller  AS , Rossi  AB , Lucky  AW .  Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled study.   Pediatr Dermatol. 2012;29(5):598-604. doi:10.1111/j.1525-1470.2012.01811.xPubMedGoogle ScholarCrossref
126.
Veraldi  S , Micali  G , Berardesca  E , Dall’Oglio  F , Sinagra  JL , Guanziroli  E .  Results of a multicenter, randomized, controlled trial of a hydrogen peroxide-based kit versus a benzoyl peroxide-based kit in mild-to-moderate acne.   J Clin Aesthet Dermatol. 2016;9(10):50-54.PubMedGoogle Scholar
127.
Tsianakas  A , Bhatia  N , Alikunju  S ,  et al.  DFD-29, a low dose oral minocycline, demonstrates superior efficacy as compared to placebo and Oraycea capsules (doxycycline HCl) in subjects with papulopustular rosacea.   Skin J Cutan Med. 2019;3:S11. doi:10.25251/skin.3.supp.11Google ScholarCrossref
128.
Alexis  A , Del Rosso  JQ , Desai  SR ,  et al.  BPX-01 minocycline topical gel shows promise for the treatment of moderate-to-severe inflammatory acne vulgaris.   J Clin Aesthet Dermatol. 2018;11(11):25-35.PubMedGoogle Scholar
129.
Anyachukwu  CC , Onyeso  OKK .  Efficacy of adjunct (laser) therapy to topical agents among Southern Nigerian acne vulgaris patients.   Acupunct Relat Ther. 2014;2(4):66-70. doi:10.1016/j.arthe.2014.08.003Google ScholarCrossref
130.
Sitohang  IBS , Yahya  YF , Simanungkalit  R , Adi Winarni  DR , Madjid  A .  Efficacy and tolerability of topical nicotinamide plus antibacterial adhesive agents and zinc-pyrrolidone carboxylic acid versus placebo as an adjuvant treatment for moderate acne vulgaris in indonesia: a multicenter, double-blind, randomized, controlled trial.   J Clin Aesthet Dermatol. 2020;13(7):27-31.PubMedGoogle Scholar
131.
Nestor  MS , Swenson  N , Macri  A , Manway  M , Paparone  P .  Efficacy and tolerability of a combined 445nm and 630nm over-the-counter light therapy mask with and without topical salicylic acid versus topical benzoyl peroxide for the treatment of mild-to-moderate acne vulgaris.   J Clin Aesthet Dermatol. 2016;9(3):25-35.PubMedGoogle Scholar
132.
Baldwin  H , Blanco  D , McKeever  C ,  et al.  Results of a phase 2 efficacy and safety study with SB204, an investigational topical nitric oxide-releasing drug for the treatment of acne vulgaris.   J Clin Aesthet Dermatol. 2016;9(8):12-18.PubMedGoogle Scholar
133.
Eichenfield  LF , Lain  T , Frankel  EH ,  et al.  Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: second of two identically designed, large, multicenter, randomized, vehicle-controlled trials.   J Drugs Dermatol. 2016;15(8):962-969.PubMedGoogle Scholar
134.
Feldman  SR , Werner  CP , Alió Saenz  AB .  The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.   J Drugs Dermatol. 2013;12(4):438-446.PubMedGoogle Scholar
135.
Bhatia  N , Weiss  JS , Sadick  N ,  et al.  Novel polymeric tazarotene 0.045% lotion for moderate-to-severe acne: pooled phase 3 analysis by race/ethnicity.   J Drugs Dermatol. 2020;19(7):727-734. doi:10.36849/JDD.2020.5125PubMedGoogle ScholarCrossref
136.
Tanghetti  EA , Kircik  LH , Green  LJ ,  et al.  a phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a novel tazarotene 0.045% lotion and tazarotene 0.1% cream in the treatment of moderate-to-severe acne vulgaris.   J Drugs Dermatol. 2019;18(6):542-542.PubMedGoogle Scholar
137.
Stein  L , Kircik  L , Fowler  J ,  et al.  Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.   J Drugs Dermatol. 2014;13(3):316-323.PubMedGoogle Scholar
138.
Pariser  DM , Rich  P , Cook-Bolden  FE , Korotzer  A .  An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.   J Drugs Dermatol. 2014;13(9):1083-1089.PubMedGoogle Scholar
139.
Palli  MB , Reyes-Habito  CM , Lima  XT , Kimball  AB .  A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris.   J Drugs Dermatol. 2013;12(6):633-637.PubMedGoogle Scholar
140.
Gold  LS , Papp  K , Lynde  C ,  et al.  Treatment of rosacea with concomitant use of topical ivermectin 1% cream and brimonidine 0.33% gel: a randomized, vehicle-controlled study.   J Drugs Dermatol. 2017;16(9):909-916.PubMedGoogle Scholar
141.
Tyring  SK , Kircik  LH , Pariser  DM , Guenin  E , Bhatt  V , Pillai  R .  Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of efficacy and safety in patients aged 9 years and older.   J Drugs Dermatol. 2018;17(10):1084-1091.PubMedGoogle Scholar
142.
Eichenfield  LF , Draelos  Z , Lucky  AW ,  et al.  Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.   J Drugs Dermatol. 2013;12(6):611-618.PubMedGoogle Scholar
143.
Takigawa  M , Tokura  Y , Shimada  S , Furukawa  F , Noguchi  N , Ito  T ; Acne Study Group.  Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris.   J Dermatol. 2013;40(8):620-625. doi:10.1111/1346-8138.12189PubMedGoogle ScholarCrossref
144.
Moore  A , Ling  M , Bucko  A , Manna  V , Rueda  MJ .  Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study.   J Drugs Dermatol. 2015;14(6):581-586.PubMedGoogle Scholar
145.
Webster  GF , Leyden  JJ , Gross  JA .  Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.   J Drugs Dermatol. 2014;13(6):665-670.PubMedGoogle Scholar
146.
Rosso  JQ , Draelos  ZD , Effron  C , Kircik  LH .  Oral sarecycline for treatment of papulopustular rosacea: results of a pilot study of effectiveness and safety.   J Drugs Dermatol. 2021;20(4):426-431. doi:10.36849/JDD.5923PubMedGoogle ScholarCrossref
147.
Moore  A , Green  LJ , Bruce  S ,  et al.  Once-daily oral sarecycline 1.5 mg/kg/day is effective for moderate to severe acne vulgaris: results from two identically designed, phase 3, randomized, double-blind clinical trials.   J Drugs Dermatol. 2018;17(9):987-996.PubMedGoogle Scholar
148.
Leyden  JJ .  Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.   J Drugs Dermatol. 2011;10(10):1179-1185.PubMedGoogle Scholar
149.
Santos-Caetano  JP , Cargill  MR .  A randomized controlled tolerability study to evaluate reformulated benzoyl peroxide face washes for acne vulgaris.   J Drugs Dermatol. 2019;18(4):350-356.PubMedGoogle Scholar
150.
Chang  ALS , Alora-Palli  M , Lima  XT ,  et al.  A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.   J Drugs Dermatol. 2012;11(3):333-339.PubMedGoogle Scholar
151.
Jackson  JM , Coulon  R , Arbiser  JL .  Evaluation of a first-in-class proteasome inhibitor in patients with moderate to severe rosacea.   J Drugs Dermatol. 2021;20(6):660-664. doi:10.36849/JDD.2021.5925PubMedGoogle Scholar
152.
Leyden  JJ , Sniukiene  V , Berk  DR , Kaoukhov  A .  Efficacy and safety of sarecycline, a novel, once-daily, narrow spectrum antibiotic for the treatment of moderate to severe facial acne vulgaris: results of a phase 2, dose-ranging study.   J Drugs Dermatol. 2018;17(3):333-338.PubMedGoogle Scholar
153.
DuBois  J , Dover  JS , Jones  TM , Weiss  RA , Berk  DR , Ahluwalia  G .  Phase 2 randomized, dose-ranging study of oxymetazoline cream for treatment of persistent facial erythema associated with rosacea.   J Drugs Dermatol. 2018;17(3):308-316.PubMedGoogle Scholar
154.
Stein Gold  LF , Jarratt  MT , Bucko  AD ,  et al.  Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: first of two identically designed, large, multicenter, randomized, vehicle-controlled trials.   J Drugs Dermatol. 2016;15(5):553-561.PubMedGoogle Scholar
155.
Eichenfield  LF , Gold  LS , Nahm  WK , Cook-Bolden  FE , Pariser  DM .  Results of a phase 2, randomized,vehicle-controlled study evaluating the efficacy,tolerability, and safety of daily or twice daily sb204 for the treatment of acne vulgaris.   J Drugs Dermatol. 2016;15(12):1496-15027.PubMedGoogle Scholar
156.
Faghihi  G , Khosravani  P , Nilforoushzadeh  MA ,  et al.  Dapsone gel in the treatment of papulopustular rosacea: a double-blind randomized clinical trial.   J Drugs Dermatol. 2015;14(6):602-606.PubMedGoogle Scholar
157.
Weiss  J , Stein Gold  L , Leoni  M , Rueda  MJ , Liu  H , Tanghetti  E .  Customized single-agent therapy management of severe inflammatory acne: a randomized, double-blind, parallel-group, controlled study of a new treatment—adapalene 0.3%-benzoyl peroxide 2.5% gel.   J Drugs Dermatol. 2015;14(12):1427-1435.PubMedGoogle Scholar
158.
Leyden  JJ .  Randomized, phase 2, dose-ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gel.   J Drugs Dermatol. 2014;13(6):685-688.PubMedGoogle Scholar
159.
Leyden  JJ , Bruce  S , Lee  CS ,  et al.  A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.   J Drugs Dermatol. 2013;12(6):658-663.PubMedGoogle Scholar
160.
Jackson  JM , Kircik  LH , Lorenz  DJ .  Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea.   J Drugs Dermatol. 2013;12(3):292-298.PubMedGoogle Scholar
161.
Freeman  SA , Moon  SD , Spencer  JM .  Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: summary of a placebo-controlled, double-blind trial.   J Drugs Dermatol. 2012;11(12):1410-1414.PubMedGoogle Scholar
162.
Eichenfield  LF , Alió Sáenz  AB .  Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.   J Drugs Dermatol. 2011;10(12):1382-1396.PubMedGoogle Scholar
163.
Tanghetti  E , Dhawan  S , Green  L ,  et al.  Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.   J Drugs Dermatol. 2011;10(7):783-792.PubMedGoogle Scholar
164.
Kim  JH , Oh  YW , Kim  DH , Seo  BH , Suh  HS , Choi  YS .  A randomized, placebo-controlled trial of gamma linolenic acid as an add-on therapy to minocycline for the treatment of rosacea.   Ann Dermatol. 2020;32(6):466-472. doi:10.5021/ad.2020.32.6.466PubMedGoogle ScholarCrossref
165.
Deshmukh  SN , Badar  VA , Mahajan  MM , Dudhgaonkar  DS , Mishra  D .  Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne.   Perspect Clin Res. 2018;9(4):161-164. doi:10.4103/picr.PICR_109_17PubMedGoogle Scholar
166.
Choudhury  S , Chatterjee  S , Sarkar  DK , Dutta  RN .  Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial.   Indian J Pharmacol. 2011;43(6):628-631. doi:10.4103/0253-7613.89815PubMedGoogle Scholar
167.
Massi  MN , Yunus  M , Anwar  AI ,  et al.  The effectiveness of autologous serum and single-dose oral doxycycline in the treatment of acne vulgaris: a pilot clinical trial.   Open Access Maced J Med Sci. 2021;9(B):1602-1606. doi:10.3889/oamjms.2021.6874Google ScholarCrossref
168.
Van  TN , Thi  LD , Trong  HN ,  et al.  Efficacy of oral isotretinoin in combination with desloratadine in the treatment of common vulgaris acne in vietnamese patients.   Open Access Maced J Med Sci. 2019;7(2):217-220. doi:10.3889/oamjms.2019.054PubMedGoogle ScholarCrossref
169.
Rassai  S , Mehri  M , Yaghoobi  R , Sina  N , Mohebbipour  A , Feily  A .  Superior efficacy of azithromycin and levamisole vs. azithromycin in the treatment of inflammatory acne vulgaris: an investigator blind randomized clinical trial on 169 patients.   Int J Clin Pharmacol Ther. 2013;51(6):490-494. doi:10.5414/CP201861PubMedGoogle ScholarCrossref
170.
Dhawan  SS , Gwazdauskas  J .  Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.   Cutis. 2013;91(2):99-104.PubMedGoogle Scholar
171.
Draelos  ZD , Elewski  BE , Harper  JC ,  et al.  A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.   Cutis. 2015;96(1):54-61.PubMedGoogle Scholar
172.
Draelos  ZD , Elewski  B , Staedtler  G , Havlickova  B .  Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.   Cutis. 2013;92(6):306-317.PubMedGoogle Scholar
173.
Draelos  ZD , Shalita  AR , Thiboutot  D , Oresajo  C , Yatskayer  M , Raab  S .  A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.   Cutis. 2012;89(6):287-293.PubMedGoogle Scholar
174.
Martel  P , Jarratt  M , Weiss  J , Carlavan  I .  Lack of significant anti-inflammatory activity with clindamycin in the treatment of rosacea: results of 2 randomized, vehicle-controlled trials.   Cutis. 2017;100(1):53-58.PubMedGoogle Scholar
175.
Solomon  JA , Tyring  S , Staedtler  G , Sand  M , Nkulikiyinka  R , Shakery  K .  Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trial.   Cutis. 2016;98(3):187-194.PubMedGoogle Scholar
176.
Mokhtari  F , Gholami  M , Siadat  AH ,  et al.  Efficacy of intense-pulsed light therapy with topical benzoyl peroxide 5% versus benzoyl peroxide 5% alone in mild-to-moderate acne vulgaris: a randomized controlled trial.   J Res Pharm Pract. 2017;6(4):199-205. doi:10.4103/jrpp.JRPP_17_29PubMedGoogle ScholarCrossref
177.
Mehran  G , Sepasgozar  S , Rohaninasab  M ,  et al.  Comparison between the therapeutic effect of microneedling versus tretinoin in patients with comedonal acne: a randomized clinical trial.   Iran J Dermatol. 2019;22(3):87-91. doi:10.22034/IJD.2019.100199Google Scholar
178.
Moravvej  H , Mousazadeh Halim  A , Yousefi  M , Givrad  S .  Efficacy of doxycycline versus azithromycin in the treatment of moderate facial acne vulgaris.   Iran J Dermatol. 2012;15(1):7-10.Google Scholar
179.
Sugat  AJ , Vaidehi  AS , Ambika  RK .  Efficacy and tolerability of adapalene 0.1%-benzoyl peroxide 2.5% combination gel in treatment of acne vulgaris in Indian patients: a randomized investigator-blind controlled trial.   Iran J Dermatol. 2016;19(4):105-112.Google Scholar
180.
Faghihi  G , Rakhshanpour  M , Abtahi-Naeini  B , Nilforoushzadeh  MA .  The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: A randomized double-blind study.   Adv Biomed Res. 2014;3(1):177. doi:10.4103/2277-9175.139413PubMedGoogle ScholarCrossref
181.
Fatemi  F , Najafian  J , Nasab  SS , Nilforoushzadeh  MA .  Treatment of acne vulgaris using the combination of topical erythromycin and miconazole.   J Skin Stem Cell. 2014;1(3):23330. doi:10.17795/jssc23330Google ScholarCrossref
182.
Khorvash  F , Abdi  F , Kashani  HH , Fatemi Naeini  F , Khorvash  F .  Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris.   Iran J Pharm Res. 2013;12(1):223-227.PubMedGoogle Scholar
183.
Gurung  S , Patil  N , Rao  K ,  et al.  A comparative study on efficacy of azithromycin and doxycycline in the treatment of acne vulgaris at a tertiary care centre.   Biomed Pharmacol J. 2020;13(3):1451-1455. doi:10.13005/bpj/2016Google ScholarCrossref
184.
Hussain  S , Mustafa  A , Mumtaz  A , Soban  M , Shaheen  G , Ahmad  S .  Comparison of efficacy of azithromycin and levamisole in combination with azithromycin in patients of moderate to severe acne.   Pak J Med Health Sci. 2021;15(9):2444-2446. doi:10.53350/pjmhs211592444Google ScholarCrossref
185.
Anjum  K , Altaf  F , Shahzadi  N , Nabi  H , Jafri  M , Tahir  Z .  Comparison of efficacy of 0.1% tazarotene versus 0.1% adapalene for the treatment of mild acne vulgaris.   Pak J Med Health Sci. 2020;14(1):63-66.Google Scholar
186.
Kabir  M , Sadiq  S , Raza  A , Kanwal  S , Tanvir  T .  Comparison of efficacy of adapalene (0.1% gel) monotherapy ve adapalene (0.1%) plus benzyl peroxide (2.5%) combination therapy for treatment of mild to moderate acne vulgaris.   Pak J Med Health Sci. 2018;12(2):587-589.Google Scholar
187.
Mahmoudi  M , Hajheydari  Z , Vahidshahi  K , Nozari  A .  Comparison of efficacy of azithromycin vs. clindamycin and erythromycin in the treatment of mild to moderate acne vulgaris.   Pak J Med Sci. 2011;27(1):68-72. Google Scholar
188.
Pandey  D , Agrawal  S .  Efficacy of isotretinoin and antihistamine versus isotretinoin alone in the treatment of moderate to severe acne: a randomised control trial.   Kathmandu Univ Med J (KUMJ). 2019;17(65):14-19. KUMJ.PubMedGoogle Scholar
189.
Paracha  MM , Zahoor  H , Afridi  I , Kammal  K .  Efficacy and safety of short term use of 0.1% tazarotene gel in the treatment of mild to moderate acne vulgaris: a randomized-vehicle controlled trial.   J Postgrad Med Inst. 2020;34(2).Google Scholar
190.
Özgen  Z , Gürbüz  O .  A randomized, double-blind comparison of nadifloxacin 1% cream alone and with benzoyl peroxide 5% lotion in the treatment of mild to moderate facial acne vulgaris.   Marmara Med J. 2013;26:17-20.Google Scholar
191.
El Refaei  AM , Abdel Salam  HA , Sorour  NE .  Salicylic–mandelic acid versus glycolic acid peels in Egyptian patients with acne vulgaris.   J Egypt Women Dermatol Soc. 2015;12(3):196-202. doi:10.1097/01.EWX.0000464740.18592.42Google ScholarCrossref
192.
Zaib  D , Naqvi  F , Rashid  S , Inayat  S , Ilyas  A , Faraz  AAK .  To assess the efficacy of isotretinoin in acne vulgaris with daily versus pulse therapy.   J Pak Assoc Dermatol. 2020;30(2):271-276.Google Scholar
193.
Hafeez  L , Khan  AN , Aslam  A , Tahir  R , Shafi  A , Akhtar  A .  Comparison of safety and efficacy of low dose isotretinoin versus the conventional dosing regime in the treatment of acne vulgaris.   J Pak Assoc Dermatol. 2020;30(3):423-427.Google Scholar
194.
Khan  M , Khan  NU , Anwar  MI , Noor  SM .  A comparison of the efficacy of topical adapalene gel 0.1% with tretinoin gel 0.025% in mild acne vulgaris.   J Pak Assoc Dermatol. 2017;27(1):37-41.Google Scholar
195.
Mohammadi  S , Farajzadeh  S , Pardakhti  A ,  et al.  A survey to compare the efficacy of niosomal erythromycin alone versus combination of erythromycin and zinc acetate in the treatment of acne vulgaris.   J Kerman Univ Med Sci. 2017;24(5):420-430.Google Scholar
196.
Üstüner  P , Güleç  AT , Demirbilek  M .  Clinical and bacteriological evaluation of nadifloxacin 1% cream versus erythromycin 4% gel in the treatment of mild-to-moderate facial acne vulgaris: a randomized study.   Turk Klin Tip Bilim Derg. 2015;35(2):97-105. doi:10.5336/medsci.2015-43531Google ScholarCrossref
197.
Kar  BR , Tripathy  S , Panda  M .  Comparative study of oral isotretinoin versus oral isotretinoin + 20% salicylic Acid peel in the treatment of active acne.   J Cutan Aesthet Surg. 2013;6(4):204-208. doi:10.4103/0974-2077.123403PubMedGoogle ScholarCrossref
198.
Afzali  BM , Yaghoobi  E , Yaghoobi  R , Bagherani  N , Dabbagh  MA .  Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.   J Dermatolog Treat. 2012;23(1):21-25. doi:10.3109/09546634.2010.488260PubMedGoogle ScholarCrossref
199.
Ahmadvand  A , Yazdanfar  A , Yasrebifar  F , Mohammadi  Y , Mahjub  R , Mehrpooya  M .  Evaluating the effects of oral and topical simvastatin in the treatment of acne vulgaris: a double-blind, randomized, placebo-controlled clinical trial.   Curr Clin Pharmacol. 2018;13(4):279-283. doi:10.2174/1574884713666180821143545PubMedGoogle ScholarCrossref
200.
Khodaeinai  E , Babaeinejad  S , Amirnia  M ,  et al.  Efficacy of 10% azelaic acid gel with hydro-alcoholic or alcohol-free bases in mild to moderate acne vulgaris: the first clinical trial.   J Med Sci (Faisalabad). 2014;14(2):87-91. doi:10.3923/jms.2014.87.91Google ScholarCrossref
201.
Ullah  G , Noor  SM , Bhatti  Z , Ahmad  M , Bangash  AR .  Comparison of oral azithromycin with oral doxycycline in the treatment of acne vulgaris.   J Ayub Med Coll Abbottabad. 2014;26(1):64-67.PubMedGoogle Scholar
202.
Maleszka  R , Turek-Urasinska  K , Oremus  M , Vukovic  J , Barsic  B .  Pulsed azithromycin treatment is as effective and safe as 2-week-longer daily doxycycline treatment of acne vulgaris: a randomized, double-blind, noninferiority study.   Skinmed. 2011;9(2):86-94.PubMedGoogle Scholar
203.
Montes  LF , Wilborn  WH , Montes  CM .  Topical acne treatment with acetylcysteine: clinical and experimental effects.   Skinmed. 2012;10(6):348-351.PubMedGoogle Scholar
204.
Jurairattanaporn  N , Chalermchai  T , Ophaswongse  S , Udompataikul  M .  Comparative trial of silver nanoparticle gel and 1% clindamycin gel when use in combination with 2.5% benzoyl peroxide in patients with moderate acne vulgaris.   J Med Assoc Thai. 2017;100(1):78-85.PubMedGoogle Scholar
205.
Webster  GF , Sugarman  J , Levy-Hacham  O , Toledano  O .  Microencapsulated benzoyl peroxide and tretinoin for the treatment of acne vulgaris: results from a phase 2 multicenter, double-blind, randomized, vehicle-controlled study.   Skinmed. 2020;18(6):343-351.PubMedGoogle Scholar
206.
Barbieri  JS , Gelfand  JM .  Patient-reported outcome measures as complementary information to clinician-reported outcome measures in patients with psoriasis.   JAMA Dermatol. 2021;157(10):1236-1237. doi:10.1001/jamadermatol.2021.3341 PubMedGoogle ScholarCrossref
207.
Feldman  SR , Regnier  SA , Chirilov  A , Hey  F , Gilloteau  I , Cella  D .  Patient-reported outcomes are important elements of psoriasis treatment decision making: a discrete choice experiment survey of dermatologists in the United States.   J Am Acad Dermatol. 2019;80(6):1650-1657. doi:10.1016/j.jaad.2019.01.039 PubMedGoogle ScholarCrossref
208.
US Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims. December 2009. Accessed October 27, 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims
209.
Barbieri  JS , Gelfand  JM .  Responsiveness of the EuroQol 5-dimension 3-level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the USA.   Br J Dermatol. 2019;181(5):1088-1090. doi:10.1111/bjd.18142 PubMedGoogle ScholarCrossref
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close